RepliCel Life Sciences Inc.

(RP:APH)

By |

Profile

RepliCel Life Sciences Inc is a Canadian regenerative medicine company. It focuses on developing autologous cell therapies that treat functional cellular deficits. The company addresses various diseases such as chronic tendinosis, skin aging, and androgenetic alopecia (pattern baldness). The development program of the company is based on distinct technology which utilizes cells isolated from a patient's own healthy hair follicles. In addition, the company develops a programmable cell injector device designed for dermal injections of cells, dermal filler products, and a variety of other products injected through the skin. The treatments delivered by the company uses autologous cell therapy which is developed for the treatment of androgenetic alopecia (pattern baldness).

Contact Information

Website: www.replicel.com
Email: info@replicel.com
Main Phone: +1 604 248-8730
Address: 401 West Georgia Street
Address 2: Suite 2020
State: BC
City / Town: Vancouver
Country: CAN
Postal Code: V6B 5A1

Issuer Information

Exchange: CDX
CEO: R. Lee Buckler
Employees: 1
NAICS: Research and Development in the Physical(541715)


Gathering Data... Please wait

Profile

RepliCel Life Sciences Inc is a Canadian regenerative medicine company. It focuses on developing autologous cell therapies that treat functional cellular deficits. The company addresses various diseases such as chronic tendinosis, skin aging, and androgenetic alopecia (pattern baldness). The development program of the company is based on distinct technology which utilizes cells isolated from a patient's own healthy hair follicles. In addition, the company develops a programmable cell injector device designed for dermal injections of cells, dermal filler products, and a variety of other products injected through the skin. The treatments delivered by the company uses autologous cell therapy which is developed for the treatment of androgenetic alopecia (pattern baldness).

Contact Information

Website: www.replicel.com
Email: info@replicel.com
Main Phone: +1 604 248-8730
Address: 401 West Georgia Street
Address 2: Suite 2020
State: BC
City / Town: Vancouver
Country: CAN
Postal Code: V6B 5A1

Issuer Information

Exchange: CDX
CEO: R. Lee Buckler
Employees: 1
NAICS: Research and Development in the Physical(541715)
(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange TSXV